UG, PG Admission Open | 2024-25
Apply Now
B.Tech | M.Tech | BCA | MCA
Apply Now
B.Com | M.Com | BBA | MBA
Apply Now
LLB | LLM | B.Arch
Apply Now
BJMC | MJMC | B.Design | M.Design
Apply Now
Allied Health Science | Pharmacy | Basic Sciences
Apply Now
Social Sciences | Nursing
Apply Now
Fee Payment (EMI)
Dr.Farah Deeba

Dr.Farah Deeba

Assistant Professor, Pharmacy


Dr.Farah Deeba has done Ph.D. in Pharamcology, M.Pharm(Pharmacology) and B.Pharm from Jamia Hamdard NIRF no.1(2022) . PGDDRA from Jamia Hamdard.


  • Research experience 7 years, Teaching 2.5 Years
  • PhD (Pharmacology)
Award & Recognition

  • Awarded for best impact factor in Drug Discovery Today by Jamia Hamdard on National Science Day 2022.
  • Awarded for best scholar Project by SGT university 2023.


  • Evaluation of Hepatoprotective and Antioxidant Activity of Unani Formulation (SAFI) Dated: 31-05- 2019, Indian. Journal of. Unani Medicine., Vol.12, Iss.1, PP 27- 38, January- June 2019.
  • Insect Venom peptides as potent inhibitors of Escherichia coli ATP synthase.   Journal: International Journal Biological of Macromolecules. IF: 6.953
  • Targeting ECS in diabesity: Fact or Fiction. Journal: Drug Discovery Today. IF: 8.369.
  • Synthesis, molecular docking, and pharmacological evaluation of 5-(4- (2-(5- ethylpyridine-2-yl) ethoxy) benzyl)-3-(phenylsulfonyl) thiazolidine-2,        4-dione against HFD-induced diabesity via interaction with the CB1 receptor Farah Deeba 1, Mohammad Shahar Yar 2, Mohammad Rafi Haidar.IF:3.51.
  • Versatile Therapeutic Potential of Gabapentin Mohit Yadav, Farah Deeba2, Silky Sethi.Journal: Journal of Pharmaceutical Negative Results.


  • IPGA member, Association of young Pharma Professionals

Area of Interest

  • Endocannabinoid System,Diabesity,CB1 antagonism